SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDsw Capital Regulatory News (DSW)

Share Price Information for Dsw Capital (DSW)

Share Price is delayed by 15 minutes
Get Live Data
40.00    -2.00 (-4.76%)
Bid:
35.00
Ask:
45.00
Spread: 10.00 (28.571%)
Market Cap: £10.05m
DSW Live PriceLast checked at - London Stock Exchange

Intraday Dsw Capital Share Chart

Director / PDMR Shareholding

29 Sep 2025 14:43

RNS Number : 2600B
DSW Capital PLC
29 September 2025
 

29 September 2025

DSW CAPITAL PLC

 

("DSW Capital" or "DSW" or the "Company")

 

Director / PDMR Shareholding

 

DSW Capital (AIM: DSW), a profitable, mid-market, challenger professional services licence network and owner of the Dow Schofield Watts and the DR Solicitors brands, has been informed that James Dow, Executive Director of the Company, a Person Discharging Managerial Responsibilities ("PDMR"), purchased 120,000 ordinary shares of 0.25p each in the Company ("Ordinary Shares") at 52.75p per Ordinary Share.

 

Following the purchase, James Dow's total beneficial interest in the Company comprises 4,260,827 Ordinary Shares, representing 16.95% of the issued share capital of the Company.

 

Enquiries:

 

DSW Capital

Shru Morris, CEO

James Dow, Executive Director

Pete Fendall, CFOO

 

Tel: +44 (0) 1928 378 100

Shore Capital (Nominated Adviser & Broker)

James Thomas / Mark Percy / George Payne (Corporate Advisory)

Guy Wiehahn (Corporate Broking)

 

Tel: +44 (0)20 7408 4090

Rawlings Financial PR Limited

Cat Valentine

dswcapital@rfpr.co.uk

Tel: +44 (0) 7715 769 078

 

About DSW Capital

 

DSW Capital, owner of the Dow Schofield Watts and DR Solicitors brands, is a profitable, mid-market, challenger professional services network with a cash generative business model and scalable platform for growth. Originally established in 2002, by three KPMG alumni, Dow Schofield Watts is one of the first platform models disrupting the traditional model of accounting professional services firms. DSW Capital operates licensing arrangements with its businesses and has over 140 fee earners across 12 offices in the UK. These businesses trade primarily under the Dow Schofield Watts and DR Solicitors brands.

 

DSW Capital's vision is for our brands to become the most sought-after destinations for ambitious, entrepreneurial professionals to start and develop their own businesses. Through a licensing model, DSW Capital gives professionals the autonomy and flexibility to fulfil their potential.

 

Being part of the DSW Capital group brings support benefits in recruitment, funding and infrastructure. DSW Capital's challenger model attracts experienced, senior professionals, who want to launch their own businesses and recognise the value of DSW Capital's brands and the synergies which come from being part of the network.

 

DSW Capital aims to scale its agile model through organic growth, geographical expansion, additional service lines and acquisitions. The Directors are targeting high margin, complementary, niche service lines with a strong synergistic fit with the existing network.

 

Further details of the PDMR dealing are included below.

 

This information has been provided in accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018.

 

  1

 

Details of the person discharging managerial responsibilities / person closely associated 

a)

 

Names 

James Dow

2

 

Reason for the notification

a)

 

Position/status

 

Executive Director

b)

 

Initial notification /Amendment 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

 

Name 

DSW Capital plc

b)

 

LEI

213800KKIQCIJT6TGH23

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Ordinary Shares of 0.25p each

b)

Identification code 

 

GB00BNG9H550

c)

 

Nature of the transaction 

 

Purchase of Ordinary Shares

d)

 

Price(s) and volume(s)

Price(s)

Volume(s)

52.75p

120,000

d)

 

Aggregated information 

- Aggregated volume

- Price

 

As above

e)

 

Date of the transaction 

29 September 2025

f)

 

Place of the transaction

AIM, London Stock Exchange

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSEEFDUEISELU
12
Date   Source Headline
3rd Jun 20262:26 pmRNSHolding(s) in Company
15th May 20267:00 amRNSTrading Update & Notice of Results
16th Mar 20267:00 amRNSTrading Update
16th Mar 20267:00 amRNSTrading Update
5th Jan 20269:17 amRNSHoldings in Company
24th Nov 20254:25 pmRNSHolding(s) in Company
24th Nov 20257:00 amRNSHalf Year Results
13th Nov 20257:00 amRNSHalf Year Trading Update and Notice of Results
7th Oct 20257:00 amRNS-RMello Investor Presentation
30th Sep 20257:00 amRNSHolding(s) in Company
29th Sep 20252:43 pmRNSDirector / PDMR Shareholding
16th Sep 202512:18 pmRNSResult of AGM
6th Aug 20257:00 amRNSGrant of options under Performance Share Plan
9th Jul 20251:45 pmRNSHolding(s) in Company
8th Jul 20257:00 amRNSFinal Results FY25
2nd Jul 20257:00 amRNS-RFY25 Results Presentation
15th May 20257:00 amRNSTrading Update and Notice of Results
17th Mar 20253:30 pmRNSHolding(s) in Company
7th Jan 202510:15 amRNSHolding(s) in Company
18th Dec 20243:29 pmRNSHolding(s) in Company
13th Dec 20244:56 pmRNSTR-1: Notification of Major Holdings
12th Dec 20247:00 amRNSHolding(s) in Company
11th Dec 20247:00 amRNSDirector/PDMR Shareholding
25th Nov 20247:00 amRNSGrant of awards under Performance Share Plan
25th Nov 20247:00 amRNSBoard Changes & Succession Planning
25th Nov 20247:00 amRNSHalf Year Results
7th Nov 20247:00 amRNSTrading Update, Notice of Results and Presentation
4th Nov 20247:00 amRNSAcquisition, Issue of Equity, RCF, and TVR
29th Oct 20247:00 amRNSDirectorate Change
24th Sep 20241:06 pmRNSResult of AGM
10th Jul 20249:35 amRNSGrant of awards under Performance Share Plan
10th Jul 20247:00 amRNSDirector/PDMR Shareholding
4th Jul 20247:00 amRNSDirector/PDMR Shareholding
2nd Jul 20247:00 amRNSAudited Final Results
11th Jun 20247:00 amRNSAppointment of Deputy CEO
15th May 20247:00 amRNSTrading Update and Notice of Final Results
2nd Apr 20247:00 amRNSAppointment of COO and Interim CFO
15th Feb 20247:00 amRNSTrading Update
17th Jan 20247:00 amRNSBoard Update
7th Dec 20234:30 pmRNSDirector/PDMR Shareholding
29th Nov 20237:00 amRNSDirector/PDMR Shareholding
27th Nov 20237:00 amRNSHalf Year Results
21st Nov 20237:00 amRNSHalf Year Online Results Presentation
9th Nov 20237:00 amRNSTrading Update and Notice of Results
11th Oct 20237:00 amRNSChange of role: CFO becomes Deputy CEO and CFO
4th Oct 20237:00 amRNSDSW adds a further new geographic location
29th Sep 20237:00 amRNSExpansion of DSW Tax Advisory capabilities
20th Sep 20237:00 amRNSNew Geographic Location for Corporate Finance
18th Sep 20232:33 pmRNSResult of AGM
18th Jul 20235:40 pmRNSDirector/PDMR Shareholding
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.